MedTrace Logo

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

NCT02704143 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2020-10-19

Study results available
· View outcomes & findings →

Summary

The safety and efficacy of combination of SBRT with sequential S-1 in treating patients with locally advanced pancreatic cancer and poor medical conditions will be evaluated.

Conditions

Interventions

OTHER

combination of Cyberknife with S-1

Radiation therapy combined with chemotherapy

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Huo Jun Zhang, MD., PH.D · Changhai Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704143 on ClinicalTrials.gov